News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
156,331 Results
Type
Article (5434)
Company Profile (23)
Press Release (150874)
Section
Business (41257)
Career Advice (66)
Deals (7636)
Drug Delivery (6)
Drug Development (25669)
Employer Resources (5)
FDA (4700)
Job Trends (3720)
News (80019)
Policy (8215)
Tag
Academia (579)
Alliances (10421)
Alzheimer's disease (291)
Approvals (4715)
Artificial intelligence (45)
Bankruptcy (58)
Best Places to Work (3431)
Breast cancer (96)
Cancer (606)
Cardiovascular disease (41)
Career advice (62)
Cell therapy (77)
Clinical research (20988)
Collaboration (194)
Compensation (98)
COVID-19 (1778)
C-suite (35)
Data (684)
Diabetes (39)
Diagnostics (1896)
Drug discovery (26)
Earnings (19330)
Events (24253)
Executive appointments (144)
FDA (5003)
Funding (154)
Gene therapy (60)
GLP-1 (84)
Government (1205)
Healthcare (4358)
Infectious disease (1822)
IPO (3399)
Job creations (556)
Job search strategy (60)
Layoffs (44)
Legal (1639)
Lung cancer (87)
Lymphoma (56)
Manufacturing (57)
Medical device (2802)
Medtech (2802)
Mergers & acquisitions (4367)
Metabolic disorders (92)
Neuroscience (388)
NextGen Class of 2024 (712)
Non-profit (770)
Northern California (556)
Obesity (38)
Parkinson's disease (30)
Patents (31)
People (10387)
Phase I (5770)
Phase II (8871)
Phase III (8028)
Pipeline (180)
Postmarket research (956)
Preclinical (2156)
Press Release (54)
Prostate cancer (32)
Radiopharmaceuticals (65)
Rare diseases (66)
Real estate (1094)
Regulatory (5875)
Research institute (667)
Series A (29)
Southern California (395)
Startups (454)
United States (5883)
Vaccines (279)
Date
Last 7 days (77)
Last 30 days (810)
Last 365 days (10683)
2025 (42)
2024 (10824)
2023 (10276)
2022 (14252)
2021 (15448)
2020 (15196)
2019 (9338)
2018 (6865)
2017 (6860)
2016 (6472)
2015 (7848)
2014 (5710)
2013 (4764)
2012 (5452)
2011 (5653)
2010 (5671)
Location
Africa (93)
Asia (7623)
Australia (856)
California (1175)
Canada (486)
China (87)
Colorado (74)
Connecticut (91)
Delaware (61)
Europe (18157)
Florida (141)
Georgia (38)
Illinois (99)
Indiana (47)
Japan (47)
Maryland (132)
Massachusetts (962)
Minnesota (54)
New Hampshire (60)
New Jersey (1038)
New York (531)
North Carolina (734)
Northern California (556)
Ohio (29)
Pennsylvania (209)
South America (220)
Southern California (395)
Texas (207)
Virginia (30)
Washington State (120)
Wisconsin (26)
156,331 Results for "qiagen n v".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
QIAGEN N.V. to release results for Q1 2024 and hold webcast
QIAGEN N.V. announced plans to release results for the first quarter 2024.
April 9, 2024
·
1 min read
Press Releases
QIAGEN N.V. to release results for Q3 2024 and hold webcast
October 10, 2024
·
1 min read
Press Releases
QIAGEN N.V. to release results for Q4 2023 and hold webcast
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced plans to release results for the fourth quarter and full year 2023.
January 11, 2024
·
1 min read
Business
QIAGEN N.V. to release results for Q3 2023 and hold webcast
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the third quarter 2023.
October 9, 2023
·
1 min read
Business
QIAGEN N.V. to release results for Q2 2023 and hold webcast
QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the second quarter 2023.
July 24, 2023
·
1 min read
QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024
QIAGEN N.V. announced a series of new products to further enhance cancer research as well as to enable urine collection and stabilization as a new approach for liquid biopsy.
April 3, 2024
·
8 min read
Biotech Bay
QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput NGS testing labs
QIAGEN announced the release of a new version of its clinical decision support software, QIAGEN Clinical Insight Interpret, that brings significant performance and scalability enhancements tailored for high-throughput, next-generation sequencing labs moving to larger test panels and higher test volumes.
June 13, 2024
·
7 min read
Business
QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitability
QIAGEN N.V. announced results for the fourth quarter and full-year 2023.
February 6, 2024
·
8 min read
Business
QIAGEN announces Form 20-F annual report filing for 2023 results
QIAGEN N.V. announced that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December 31, 2023, with the U.S. Securities and Exchange Commission.
March 11, 2024
·
3 min read
BioCapital
QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis infections in children
QIAGEN announced that it welcomes new guidelines in the United States that recommend screening at-risk children of all ages for latent tuberculosis infection with modern blood-based tests such as QIAGEN’s market-leading QuantiFERON-TB Gold Plus.
June 27, 2024
·
7 min read
1 of 15,634
Next
